Nav: Home

Team studies smarter automatic defibrillator

March 18, 2019

SAN ANTONIO -- Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators (AICDs) that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival in patients who are at risk for sudden cardiac death.

AICDs administer shocks based on data from intra-cardiac electrocardiograms (ECGs) obtained from leads that measure the heart's electrical activity. However, do these devices receive enough information to shock accurately in all cases?

"Existing systems in patients primarily sense the ECG," said Marc D. Feldman, M.D., professor of cardiology at UT Health San Antonio. "They don't sense blood pressure or stroke volume -- how much blood is being pumped out of the heart. Since physicians in the emergency room measure blood pressure and stroke volume at the time of an abnormal heart rhythm before deciding to shock the patient, we believe AICDs should do the same."

Dr. Feldman worked with UT Austin electrical engineers Jonathan W. Valvano, Ph.D., and John A. Pearce, Ph.D., to help create a smarter implantable defibrillator.

Results presented in New Orleans

On March 17 at the American College of Cardiology's 68th Annual Scientific Session in New Orleans, Dr. Valvano and Dr. Feldman's recent graduate student, Lucas Holt, Ph.D., presented study results from his Ph.D. project. The study, conducted in large animals with heart failure, showed that a reprogrammed AICD can accurately track stroke volume in addition to ECG readings.

"In this study, we replicated what happens in humans," Dr. Feldman said. "The animals had heart failure and implanted defibrillator leads. We proved that we could use the same leads and modify the information extracted by these leads to measure stroke volume accurately."

The researchers have not studied whether the updated defibrillator eliminates unnecessary shocks, Dr. Feldman said. The hope is that, with complete information, shocks will be delivered only when needed or withheld when not needed.

More accurate identification of when to shock

"We believe people may be able to avoid unnecessary and traumatic shocks when the stroke volume is normal," Dr. Feldman said. "But when the stroke volume is low, the device will more accurately identify patients who need to be shocked. So it will help in either fashion."

JACC: Clinical Electrophysiology, a journal of the American College of Cardiology, published the findings concurrently with Dr. Holt's presentation in New Orleans. He spoke during a session titled "Highlighted Original Research." "Usually this is done only when something is deemed important to the journal reviewers and to the American College of Cardiology," Dr. Feldman said.

Manoj M. Panday, M.D., head of the Section of Cardiac Electrophysiology at UT Health San Antonio, treats defibrillator patients on a daily basis. He was not involved directly in the current studies, but said: "Detection of changes in stroke volume may help to prevent inappropriate shocks and improve the ability of the device to deliver therapy for clinically significant arrhythmias that need to be treated."

In a previous study published in the journal Heart Rhythm in October 2017, the team showed that a reprogrammed automatic defibrillator could serve as a warning system of congestive heart failure in human patients.
-end-
This research is supported by a $2 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Additional support was from the Texas Emerging Technology Fund. Dr. Feldman is the Janey Briscoe Distinguished Professor of Medicine in the Joe R. and Teresa Lozano Long School of Medicine.

Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.

The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio®, is one of the country's leading health sciences universities. With missions of teaching, research, healing and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced 36,500 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better®," visit http://www.uthscsa.edu.

University of Texas Health Science Center at San Antonio

Related Heart Failure Articles:

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.
Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
NSAID impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation.
Heart cell defect identified as possible cause of heart failure in pregnancy
A new Tel Aviv University study reveals that one of the possible primary causes of heart failure in pregnant women is a functional heart cell defect.
In heart failure, a stronger heart could spell worse symptoms
Patients with stronger-pumping hearts have as many physical and cognitive impairments as those with weaker hearts, suggesting the need for better treatment.
Patients with common heart failure more likely to have lethal heart rhythms
New Smidt Heart Institute Research shows that patients with Heart Failure with Preserved Ejection Fraction (HFpEF) are more likely to have lethal heart rhythms.
More Heart Failure News and Heart Failure Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 2: Every Day is Ignaz Semmelweis Day
It began with a tweet: "EVERY DAY IS IGNAZ SEMMELWEIS DAY." Carl Zimmer – tweet author, acclaimed science writer and friend of the show – tells the story of a mysterious, deadly illness that struck 19th century Vienna, and the ill-fated hero who uncovered its cure ... and gave us our best weapon (so far) against the current global pandemic. This episode was reported and produced with help from Bethel Habte and Latif Nasser. Support Radiolab today at Radiolab.org/donate.